Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Prognostic Value of Nerve Damage Biomarkers in Acute and Chronic Organophosphate Toxicity

NCT06021262 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.

NCT NCT06021262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06021262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Prognostic Value of Nerve Damage Biomarkers in Acute and Chronic Organophosphate Toxicity
Lead sponsor
Alexandria University
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2023
Completion date
January 31, 2024
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genotoxicity, nerve damage, nerve degeneration, nerve injury, neuroinflammatory response, neurotoxicity